Evidence map›Paper›PMID 37057819›Full record

ArticleAdvanced healthcare materials2023

Bioprinting of Stem Cell Spheroids Followed by Post-Printing Chondrogenic Differentiation for Cartilage Tissue Engineering.

Monize Caiado Decarli, Adrián Seijas-Gamardo, Francis L C Morgan, Paul Wieringa, Matthew B Baker, Jorge Vicente L Silva, Ângela Maria Moraes, Lorenzo Moroni, Carlos Mota

Open access · bronzeAbstract read
In one paragraph

Article in Advanced healthcare materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Monize Caiado DecarliMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Adrián Seijas-GamardoMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Francis L C MorganMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Paul WieringaMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Matthew B BakerMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Jorge Vicente L SilvaThree-Dimensional Technologies Research Group, CTI Renato Archer, Rodovia Dom Pedro I SP-65, Km 143,6 - Amarais, Campinas, SP, 13069-901, Brazil.
Ângela Maria MoraesDepartment of Engineering of Biomaterials and of Bioprocesses, School of Chemical Engineering, University of Campinas - UNICAMP, Av. Albert Einstein, 500, Cidade Universitária "Zeferino Vaz", Campinas, SP, 13083-852, Brazil.
Lorenzo MoroniMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.
Carlos MotaMERLN Institute for Technology-Inspired Regenerative Medicine, Department of Complex Tissue Regeneration, Maastricht University, Universiteitssingel, 40, Maastricht, Limburg, 6229 ER, the Netherlands.ORCID 0000-0001-5935-6245
Maastricht University · NLUniversidade Estadual de Campinas (UNICAMP) · BRCentro de Tecnologia da Informação Renato Archer · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cartilage tissue presents low self-repair capability and lesions often undergo irreversible progression. Structures obtained by tissue engineering, such as those based in extrusion bioprinting of constructs loaded with stem cell spheroids may offer valuable alternatives for research and therapeutic purposes. Human mesenchymal stromal cell (hMSC) spheroids can be chondrogenically differentiated faster and more efficiently than single cells. This approach allows obtaining larger tissues in a rapid, controlled and reproducible way. However, it is challenging to control tissue architecture, construct stability, and cell viability during maturation. Herein, this work reports a reproducible bioprinting process followed by a successful post-bioprinting chondrogenic differentiation procedure using large quantities of hMSC spheroids encapsulated in a xanthan gum-alginate hydrogel. Multi-layered constructs are bioprinted, ionically crosslinked, and post chondrogenically differentiated for 28 days. The expression of glycosaminoglycan, collagen II and IV are observed. After 56 days in culture, the bioprinted constructs are still stable and show satisfactory cell metabolic activity with profuse extracellular matrix production. These results show a promising procedure to obtain 3D models for cartilage research and ultimately, an in vitro proof-of-concept of their potential use as stable chondral tissue implants.

Indexed as

BioprintingTissue EngineeringCartilageCell DifferentiationHumansPrinting, Three-DimensionalStem CellsTissue Scaffoldsbioprintingchondrogenic differentiationhydrogelmesenchymal stromal cellsspheroids

Identifiers

PMID37057819
PMCPMC11468754
OpenAlexW4365479579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.